急诊治疗阵发性室上性心动过速的临床分析

Clinical Analysis on Emergency Treatment of Paroxysmal Supraventricular Tachycardia

目的探讨急诊治疗阵发性室上性心动过速(PSVT)患者的效果。方法选取我院2016年11月至2017年11月收治的68例PSVT患者,随机分为观察组和对照组各34例。观察组采用普罗帕酮药物治疗,对照组采用三磷酸腺苷药物治疗。比较两组患者的复律成功率、复律时间及不良反应发生率。结果观察组的复律率为94.12%,显著高于对照组的73.53%(P<0.05)。观察组的复律时间显著短于对照组(P<0.05)。观察组的不良反应发生率为8.82%,显著低于对照组的29.41%(P<0.05)。结论普罗帕酮药物治疗PSVT患者的复律时间较短,复律成功率较高,且不良反应发生率较低,是急诊治疗PSVT患者的首选方案之一,值得应用推广。

Objective To explore the effect of emergency treatment of patients with paroxysmal supraventricular tachycardia（PSVT）.Methods 68 cases of PSVT patients admitted to our hospital from November 2016 to November 2017 were selected and randomly divided into observation group and control group, with 34 cases in each group. The observation group was treated with propafenone drug, while the control group was treated with adenosine triphosphate drug. The success rate of cardioversion, cardioversion time and incidence of adverse reactions were compared between the two groups. Results The success rate of cardioversion of the observation group was 94.12%,significantly higher than 73.53% of the control group（P 〈0.05）. The cardioversion time of the observation group was significantly shorter than that of the control group（P 〈0.05）. The incidence of adverse reactions of the observation group was 8.82%, significantly lower than29.41% of the control group（P 〈0.05）. Conclusions Propafenone in the treatment of PSVT patients has shorter cardioversion time, higher success rate of cardioversion and lower incidence of adverse reactions, which is one of the preferred schemes for PSVT patients in emergency treatment and is worthy of application and promotion.